Olaratumab and doxorubicin versus doxorubicin alone for treatment of soft-tissue sarcoma: an open-label phase 1b and randomised phase 2 trial
| Autor: | Tap, William D *, Jones, Robin L, Van Tine, Brian A, Chmielowski, Bartosz, Elias, Anthony D, Adkins, Douglas, Agulnik, Mark, Cooney, Matthew M, Livingston, Michael B, Pennock, Gregory, Hameed, Meera R, Shah, Gaurav D, Qin, Amy, Shahir, Ashwin, Cronier, Damien M, Ilaria, Robert, Jr, Conti, Ilaria, Cosaert, Jan, Schwartz, Gary K |
|---|---|
| Zdroj: | In The Lancet 30 July-5 August 2016 388(10043):488-497 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|